Literature DB >> 31466583

Review and Update on Evidence-Based Surgical Treatment Recommendations for Nonmelanoma Skin Cancer.

Megan E Shelton1, Adewole S Adamson2.   

Abstract

Nonmelanoma skin cancer (NMSC) is the most commonly diagnosed malignancy in the United States. Surgery is considered the gold standard treatment. Techniques include curettage and electrodesiccation, surgical excision, and Mohs micrographic surgery. While each is effective, there are relative advantages and disadvantages with respect to cost, time, quality of life, and role in patients with limited life expectancy. Preventing local tumor recurrence is the primary objective; however, recurrence rates are based on retrospective data, and high-quality comparator studies assessing effectiveness are scarce. Prospective and randomized controlled trials are imperative to create comprehensive, evidence-based recommendations for the surgical management of NMSC.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Basal cell carcinoma; Curettage and electrodessication; Destruction; Excision; Mohs micrographic surgery; Nonmelanoma skin cancer; Squamous cell carcinoma; Surgical treatment

Mesh:

Year:  2019        PMID: 31466583     DOI: 10.1016/j.det.2019.05.002

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  5 in total

1.  Curettage and electrodessication combined with photodynamic therapy in the treatment of large squamous cell carcinomas in unfit and frail patients.

Authors:  Henrik Luu; Måns Cornefjord; Åke Svensson; Henry Svensson
Journal:  BMJ Case Rep       Date:  2022-06-01

2.  Design, Physicochemical Characterization, and In Vitro Permeation of Innovative Resatorvid Topical Formulations for Targeted Skin Drug Delivery.

Authors:  Victor H Ruiz; David Encinas-Basurto; Bo Sun; Basanth Babu Eedara; Sally E Dickinson; Georg T Wondrak; H -H Sherry Chow; Clara Curiel-Lewandrowski; Heidi M Mansour
Journal:  Pharmaceutics       Date:  2022-03-24       Impact factor: 6.525

3.  Metformin overcomes metabolic reprogramming-induced resistance of skin squamous cell carcinoma to photodynamic therapy.

Authors:  Marta Mascaraque-Checa; María Gallego-Rentero; Jimena Nicolás-Morala; Mikel Portillo-Esnaola; José M Cuezva; Salvador González; Yolanda Gilaberte; Ángeles Juarranz
Journal:  Mol Metab       Date:  2022-04-09       Impact factor: 8.568

4.  ORIFICE (Interventional Radiotherapy for Face Aesthetic Preservation) Study: Results of Interdisciplinary Assessment of Interstitial Interventional Radiotherapy (Brachytherapy) for Periorificial Face Cancer.

Authors:  Luca Tagliaferri; Ilaria Giarrizzo; Bruno Fionda; Mario Rigante; Monica Maria Pagliara; Calogero Casà; Claudio Parrilla; Valentina Lancellotta; Elisa Placidi; Alessandra Salvati; Gabriella Macchia; Stefano Gentileschi; Maria Antonietta Blasi; Alessio Giuseppe Morganti; Francesco Bussu; Ketty Peris; Gaetano Paludetti; Vincenzo Valentini
Journal:  J Pers Med       Date:  2022-06-24

5.  Crocin exerts anti-proliferative and apoptotic effects on cutaneous squamous cell carcinoma via miR-320a/ATG2B.

Authors:  Xiaoqing Bi; Zhenjuan Jiang; Zhaohui Luan; Daoqing Qiu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.